Virtual Medicinal Product (VMP) - Spironolactone 10mg/5ml / Chlorothiazide 250mg/5ml oral suspension

Navigation

Name Details

Name Start Date End Date
Name Current Name Spironolactone 10mg/5ml / Chlorothiazide 250mg/5ml oral suspension Start Date 30-04-2010 End Date
Previous Name Previous Name Chlorothiazide 250mg/5ml / Spironolactone 10mg/5ml oral suspension Start Date 18-10-2007 End Date 29-04-2010
Abbreviated Name Abbreviated Name Spironolactone 10mg/5ml / Chlorothiazide 250mg/5ml susp Start Date 30-04-2010
Previous Abbreviated Name Chlorothiazide 250mg/5ml / Spironolactone 10mg/5ml susp Previous Start Date 01-05-2009 Previous End Date 29-04-2010

Unit Dose & Form Information

DF Indicator
Continuous

Summary

Prescribing Status
Valid as a prescribable product
Controlled Drug Category
No Controlled Drug Status
Route
Oral
Form
Oral suspension
Ontology Form/Route
suspension.oral
Name Basis
Other

Codes

ATC Code
C03AH01
BNF Codes
  • BNF code 02020400
SNOMED Codes
Code Start Date End Date
12424611000001103 18-10-2007

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Chlorothiazide Based on Ingredient Substance 50 mg 1 ml
Spironolactone Based on Ingredient Substance 2 mg 1 ml

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
1 ml